Product Information
GENTEAL TEARS 0.1%-0.2%-0.3% is a brand product labeled by Alcon Laboratories, Inc., priced at $0.4250 per ML under NDC 00065042637. Its NADAC has been published 185 times since Mar 22, 2023.
Strength
1; 2; 3 mg/mL; mg/mL; mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
00065042637
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DEXTRAN 70; GLYCERIN; HYPROMELLOSESApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
3/1/2016
Pharmacological Classes
Price Statistics
The NADAC for GENTEAL TEARS 0.1%-0.2%-0.3% has been published 185 times since Mar 22, 2023, and over the history we have for it it has risen 3.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4250 per ML |
|---|---|
| All-time high | $0.4268 (Aug 12, 2026) |
| All-time low | $0.4096 (Mar 22, 2023) |
| 52-week high | $0.4268 |
| 52-week low | $0.4164 |
| Median price | $0.4176 |
| Average price | $0.4176 |
| Largest weekly change | +3.7% (Apr 17, 2024) |
| Weeks tracked | 185 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alcon Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextran 70, Glycerin, Hypromellose market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GENTEAL TEARS 0.1%-0.2%-0.3%?
The current National Average Drug Acquisition Cost (NADAC) for GENTEAL TEARS 0.1%-0.2%-0.3%, manufactured by Alcon Laboratories, Inc., is $0.4250 per ML (NDC 00065042637), effective Sep 30, 2026.
How has the price of GENTEAL TEARS 0.1%-0.2%-0.3% changed over time?
Over the history we have for it, the NADAC for GENTEAL TEARS 0.1%-0.2%-0.3% has risen 3.8%. It has been tracked across 185 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for GENTEAL TEARS 0.1%-0.2%-0.3%?
Since Mar 22, 2023, the NADAC for GENTEAL TEARS 0.1%-0.2%-0.3% has ranged from a low of $0.4096 (Mar 22, 2023) to a high of $0.4268 (Aug 12, 2026), with a median of $0.4176 per ML.
Are there cheaper alternatives to GENTEAL TEARS 0.1%-0.2%-0.3%?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GENTEAL TEARS 0.1%-0.2%-0.3% in a comparable dosage form, but none are currently priced below it.
Who manufactures GENTEAL TEARS 0.1%-0.2%-0.3%?
GENTEAL TEARS 0.1%-0.2%-0.3% (NDC 00065042637) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.